Abstract Attenuated strains of Sabin poliovirus vaccine replicate in the human gut and, in rare cases, may cause vaccine-associated paralytic poliomyelitis (VAPP). The genetic instability of Sabin strains constitutes one of the main causes of VAPP, a disease that is most frequently associated with type 3 and type 2 Sabin strains, and more rarely with type 1 Sabin strains. In the present study, the growth phenotype of eight oral poliovirus vaccine (OPV) isolates (two non-recombinants and six recombinants), as well as of Sabin vaccine strains, was evaluated using two different assays, the reproductive capacity at different temperatures (Rct) test and the one-step growth curve test in Hep-2 cells at two different temperatures (37°C and 40°C). The growth phenotype of isolates was correlated with genomic modifications in order to identify the determinants and mechanisms of reversion towards neurovirulence. All of the recombinant OPV isolates showed a thermoresistant phenotype in the Rct test. Moreover, both recombinant Sabin-3 isolates showed significantly higher viral yield than Sabin 3 vaccine strain at 37°C and 40°C in the one-step growth curve test. All of the OPV isolates displayed mutations at specific sites of the viral genome, which are associated with the attenuated and temperature-sensitive phenotype of Sabin strains. The results showed that both mutations and recombination events could affect the phenotype traits of Sabin derivatives and may lead to the reversion of vaccinal strains to neurovirulent ones. The use of phenotypic markers along with the genomic analysis may shed additional light on the molecular determinants of the reversed neurovirulent phenotype of Sabin derivatives.
Introduction
Poliovirus, the causal agent of poliomyelitis, is a member of the enterovirus genus of the Picornaviridae family and exists as three immunologically defined serotypes (P1, P2, and P3). The poliovirus is a nonenveloped virus composed of a 7.5-Kb positive-sense single-stranded polyadenylated RNA genome surrounded by an icosahedral capsid [1] . The capsid is made of 60 protomers, each containing a single copy of the four structural capsid proteins (VP1 to VP4). The viral RNA contains a long open reading frame flanked by 5′ and 3′ noncoding regions (5′-NCR and 3′-NCR, respectively) involved in viral replication and translation. The predicted secondary structure of the 5′-NCR defines six domains (numbered from I to VI) corresponding to highly conserved structures formed by stems and loops [2, 3] . Domains II, IV, and V and part of domain VI contribute to the internal ribosomal entry site which allows capindependent initiation of translation of the viral genome [4] . Structural and nonstructural viral proteins are coded by a single polypeptide precursor, which is cleaved by viral proteases.
Since 1960, poliomyelitis has been effectively controlled by the use of inactivated or live attenuated vaccines. The Sabin live oral poliovirus vaccine (OPV) is constituted of attenuated strains of each of the three serotypes (Sabin 1, 2, and 3), which have been selected by numerous passages of wild-type strains in monkey tissues in vivo and in vitro [5] . The Sabin strains are temperature-sensitive (ts) and the ts phenotype correlates with the attenuated phenotype [6] [7] [8] . The molecular determinants of attenuation and temperature sensitivity have been intensively studied to elucidate the mechanisms involved and to improve the safety of Sabin vaccine strains. The genome of Sabin 1 differs from that of its parental virulent Mahoney virus by 54 point mutations. Molecular determinants of the attenuation and temperature sensitivity of Sabin 1 have been found in the 5′-NCR and 3′-NCR of the genome, as well as in the regions encoding VP1, VP3, and VP4 capsid proteins and the RNA polymerase (3D) [9] [10] [11] [12] [13] [14] [15] . For Sabin types 2 and 3, the vaccine strains differ from their progenitors by 23 and 11 mutations, respectively, and there is evidence in both cases that attenuation is determined by just two or three of these mutations. One substitution in the 5′-NCR of the genome and another that changes an amino acid residue in a capsid protein (VP1 in Sabin 2 and VP3 in Sabin 3) are the major determinants of attenuation and temperature sensitivity [7, 8, [15] [16] [17] [18] [19] [20] [21] [22] .
Undoubtedly, the use of OPV in mass vaccinations has resulted in drastic reductions in the number of poliomyelitis cases due to infections with wild-type polioviruses from an estimated 350,000 cases in over 125 endemic countries in 1988 to just 1,310 cases in four countries in 2007. However, in rare cases (1 case per 750,000 primary vaccinees), OPV strains have been implicated in vaccineassociated paralytic poliomyelitis (VAPP) [23] . The underlying cause of VAPP is the genetic instability of OPV strains. During multiplication in the human intestine, mutations at specific sites of the genome are associated with the attenuated and temperature-sensitive phenotype of Sabin strains, and recombination between Sabin strains may result in the loss of the attenuated phenotype of OPV strains and the acquisition of traits characteristic of wild polioviruses, such as increased neurovirulence and loss of temperature sensitivity [24] [25] [26] . Moreover, changes are frequently observed in antigenic properties of OPV derivatives representing a selection of viral variants that are less prone to be neutralized by human antibodies [27] .
The aim of the present study was to correlate the reverted phenotypic traits of OPV isolates such as temperature sensitivity and growth kinetics with mutations and recombination events on the viral genome.
Materials and methods

Virus isolation
Virus isolation was performed from fecal samples during the period 1978-1985 from VAPP patients and healthy vaccinees in Hep-2 cells (Table 1 ) and the isolates were recultured for the purpose of the present study in Hep-2 cells. Initial isolation at that time occurred at the Hellenic Pasteur Institute and identification/serotyping was done by seroneutralization with rabbit polyclonal antibodies (National Institute for Public Health and Environment, RIVM, Bilthoven, The Netherlands), according to the enclosed instructions. To avoid viral mixtures, serial ten-fold dilutions were performed; the last dilution presenting a complete cytopathic effect (CPE) was passaged once again in Hep-2 cells, and the serotype was retested as described above. Vaccine strains (Sabin types 1, 2, and 3) used in this study were provided by the World Health Organization (WHO).
Genotyping and identification of recombinant OPV isolates
The primer pair UG52/UC53 was used for the identification of the vaccine origin and for the genotyping of the isolates [31] . The identification of recombination sites of isolates EP9, IF, ID, EP12, EP16, EP23, and the sequencing from the 2C-3D genomic region have been previously published by our group [32, 33] .
Rct marker test
Reproductive capacities at different temperatures (Rct marker) were evaluated by the Rct test. The Rct value is defined as the difference between the log 10 virus titer of a viral stock measured at the optimal temperature (37°C) and that of the supraoptimal temperature (40°C). Briefly, each virus stock was decimally diluted through 10 −7 . A 0.1-ml volume of medium containing 4 × 10 4 Hep-2 cells was added into each well of two 96-well plastic plates. A 0.1-ml volume of each virus dilution was inoculated into four wells of each of the two plates. One plate was incubated at 37°C and the other at 40°C. After 5 days of incubation at the appropriate temperatures, the titers were determined by an endpoint micromethod [34] and were expressed in log 10 50% tissue culture infective dose units (TCID 50 ) per ml. Viruses were considered to be thermosensitive (ts) if the Rct value (between 37°C and 40°C) was greater or equal to 2.00 and thermoresistant (not-ts) when the Rct value was less than 2.00.
One-step growth curve experiment One-step growth curve experiments were performed in Hep-2 cells at 37°C and 40°C, with a multiplicity of infection of 10 as determined by the titration of virus stocks on Hep-2 cells, as has been previously described [35] . Briefly, 100 μl of Hep-2 cells (10 4 cells/100 μl) were added into each well of 12 96-well plastic plates. After the cells were attached to the plates, the isolates and the reference Sabin vaccine strains (Sabin 1, Sabin 2, and Sabin 3) were each inoculated into five replica wells of the 96-well plastic plates. After the plates were rocked for 2 h at 37°C, the cells were thoroughly washed two times each with 300 μl of Eagle minimum essential medium (MEM) to remove unbound virus. Then, 100 μl of Eagle MEM was added into each well and the plates were incubated at 37°C or 40°C for 0, 1, 2, 4, 8, and 16 h. The plates were subjected to three consecutive freeze-thaw cycles and the viral titers of the supernatants were determined by the TCID 50 assay on Hep-2 cells at 37°C for each of the above-mentioned hours postinfection. The titration was repeated five times for each of the post-infection hours.
Computational analysis
ClustalW was used for alignment of the sequences (nucleotide and amino acid) of 5′-NCR, VP1, 2C, 3A, 3B, 3C, and 3D genomic regions of all virus isolates with those of the reference strains cited in GenBank (Sabin type 1: AY184219, Sabin type 2: AY184220, and Sabin type 3: AY184221). Amino acid sequences of VP1, 2C, 3A, 3B, 3C, and 3D genomic regions of all virus isolates were obtained by using Gene-Runner v3.05.
Results
Genotypes and recombination types of OPV isolates
The 5′-NCR and VP1 genotypes of isolates were identified. One strain was genotyped as Sabin 1, four strains as Sabin 2, and three strains as Sabin 3 (Table 1 ). Among the eight isolates, two (II and 729) were identified as nonrecombinant and six (EP9, IF, ID, EP12, EP16, and EP23) were identified as recombinant in one site. The recombination type was S2/S1 for four isolates (EP9, IF, ID, and EP12) and the recombination site was located in the 3D region for isolates IF and EP12, in the 3C region for isolate ID, and in the 3A region for isolate EP9. Isolates EP16 and EP23 were S3/S2 and S3/S1 recombinant, respectively, and the recombination site was located in the 2C region (Table 1) .
Temperature sensitivity of OPV isolates
The Rct marker assay is based on a comparison of the temperature-sensitive multiplication of poliovirus Sabin strains and the non-temperature-sensitive multiplication of virulent strains.
The non-recombinant Sabin-1 isolate II showed a partial reversion to non-ts phenotype with an Rct value of 2.00 units. Three of the recombinant Sabin-2 isolates (EP9, IF, and ID: S2/S1) showed a non-ts phenotype with Rct values ranging from 0.0 to 0.75 units, while one isolate (EP12: S2/S1) showed partial reversion to non-ts phenotype with an Rct value of 1.75 units. Both recombinant Sabin-3 isolates (EP16: S3/S2 and EP23: S3/S1) showed partial reversion to non-ts phenotype with Rct values of 1.0 and 1.5 units, respectively. The non-recombinant Sabin-3 isolate 729 showed a ts phenotype with an Rct value of 3.5 units ( Table 2 ). The Sabin vaccine strains (Sabin1, Sabin2, and Sabin3) exhibited, as expected, Rct values greater than 2.00 units.
One-step growth curve experiment
To determine whether the ts phenotype, as determined by the Rct assay, was indicative of growth defects, one-step growth curve experiments were carried out for each isolate. We compared the growth rates and virus yields at 37°C and 40°C of each isolate with that of the corresponding genotype of Sabin vaccine strain (Sabin 1, Sabin 2, or Sabin 3) in one-step growth experiments in Hep-2 cells.
The non-recombinant Sabin-1 isolate II replicated with kinetics similar to that of its progenitor Sabin 1 vaccine strain, showing that the viral yield rises after 2 h postinfection at 37°C (Fig. 1) , while at 40°C, its growth was blocked, as was also the case for Sabin 1 vaccine strain. However, isolate II showed 1.0 log 10 unit lower viral yield than Sabin 1 vaccine strain at the initial stages of the infectious life cycle (0-2 h post-infection), resulting in a difference of 2.5 log 10 units at 4 h post-infection.
The recombinant Sabin-2 isolates, EP9, EP12, and ID, displayed similar growth kinetics to that of their progenitor Sabin 2 vaccine strain (Fig. 2) . More specifically, they showed the same or lower viral yield than Sabin 2 vaccine strain during the infectious life cycle at both 37°C and 40°C. The recombinant Sabin-2 isolate IF also displayed similar growth kinetics to that of its progenitor Sabin 2 vaccine strain (Fig. 2) . However, it showed higher viral yield than Sabin 2 vaccine strain at 4 and 8 h post-infection at 37°C. Moreover, it showed 1.0-1.5 log 10 units higher viral yield than Sabin 2 vaccine strain at 4, 8, and 16 h post-infection at 40°C.
Both recombinant Sabin-3 isolates EP16 and EP23 showed different growth kinetics from that of their progenitor Sabin 3 vaccine strain (Fig. 3) . Isolates EP16
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Recombination type Mutations Δ logRct 40 and EP23 showed 2.0 and 1.7 log 10 units, respectively, higher viral yield than the Sabin 3 vaccine strain at 0 and 1 h post-infection. Moreover, the viral yield of isolates EP16 and EP23 rises after 1 h post-infection at 37°C, while that of Sabin 3 vaccine rises after 2 h post-infection. The isolates EP16 and EP23 replicated efficiently at both 37°C and 40°C. More specifically, the isolates EP16 and EP23 showed 2.0-3.5 and 1.0-2.0 log 10 units, respectively, higher viral yield than Sabin 3 vaccine strain at both 37°C and 40°C during the infectious life cycle. The nonrecombinant Sabin-3 isolate 729 replicated with kinetics similar to that of Sabin 3 vaccine strain at both 37°C and 40°C (Fig. 3 ).
Nucleotide and amino acid sequence analysis
In an attempt to correlate the phenotypic markers of the isolates with some molecular markers, we investigated the nucleotide and amino acid positions in the genomes of the isolates that have been involved in the attenuated and thermosensitive phenotype of Sabin vaccine strains. The nucleotide sequences of 5′-NCR, VP1, 2C, 3A, 3B, 3C, and 3D genomic regions were investigated in order to establish their respective predicted amino acid sequences. Tables 2 and 3 show the sequence differences with respect 
5665 U-C -5698 A-C 87-Arg-Ser 5720 A-C 95-Thr-Pro 5760 A-G 108-Lys-Arg 5959 G-A - In non-recombinant Sabin-1 isolate II, the mutation U525C was identified ( Table 2 ). The suppressive mutation U525C restores the stability of a base pair between nt 480 and 525 (AU in Mahoney, GU in Sabin 1, and GC in isolate II) in domain V of 5′-NCR and has been correlated with reversion to neurovirulence [6, 36] . The mutation C583G is situated in a double-stranded region of domain VI of IRES and leads to a G-G mismatch. In the VP1 coding region, the reversion at nt 2795 (A→G [Thr-106-Ala]), a well-known determinant of attenuation [6, 9] , was also identified. Amino acid residue 106 is located at the exterior of the capsid, specifically in the VP1 BC loop, and is involved in hydrophobic interactions with residue in position 90 [37] . Moreover, substitutions Ala-96-Thr and Lys-99-Asn were identified in isolate II. Both of them are highly exposed in the exterior of the capsid and are located in the N-AgI site as well as in the VP1 BC loop, which is participating in the formation of the north rim of the canyon and is involved in the binding of receptor CD155 to the virus [38] [39] [40] . Amino acid substitution Glu-168-Gly is exposed at the outer surface of the virion and is located in the EF loop, which is implicated in hydrophobic interactions with receptor CD155 [39, 40] . Amino acid substitution Gln-220-Arg is situated in the exterior of the virion, in the N-AgIIa site [38] .
All Sabin-2 isolates displayed the mutation A481G in 5′-NCR (Table 2 ). This substitution is a reversion to the wildtype genotype and has been associated with increased neurovirulence and thermoresistance [8, 10, [41] [42] [43] [44] [45] , probably by preventing a new base pair to form between residues 481 and 511, which would weaken the structure of 5′-NCR. Additionally, the mutation U398C was identified in two isolates (EP9 and IF) and the mutation U437C was identified in one isolate (EP9). These substitutions have also some effect in the attenuation and thermosensitivity of Sabin 2 vaccine strain, even though it is minor [46] . Both of these mutations are situated in a double-stranded region of domain IV of IRES and, in particular, they convert a base pair GU into GC. It is noteworthy the presence of mutation C584G in three Sabin-2 isolates (EP9, IF, and EP12), which leads to a G-G mismatch. In the VP1 coding region, amino acid substitutions in residue 143 were identified in two isolates (EP9 and EP12). Residue 143 is exposed on the external surface of the virion in the DE loop and the substitution of the attenuating Ile by Val, Thr, or Asn has been correlated with increased neurovirulence [8, 10, 41, 42, 45, 47] . In isolate EP12, the substitution Phe-136-Cys was also identified. The residue 136 is situated in the hydrocarbon-binding pocket of VP1 interacting with a sphingosine molecule. All Sabin-3 isolates displayed the mutation U472C in 5′-NCR (Table 2 ). This substitution is a reversion to the wildtype genotype and has been associated with increased neurovirulence and thermoresistance [7, 17, [48] [49] [50] . The nt 472 and 537 pair in the 5′-NCR is a predicted secondary structure. The attenuating U at nt 472 of 5′-NCR of Sabin 3 vaccine strain resulted in the alteration of a C-G base pair (nt 472-537) found in the neurovirulent wild strain P3/ Leon/37 to a U-G base pair found in Sabin 3 vaccine strain, suggesting that the attenuating phenotype is partially associated with a weakening of a base pairing in a highly conserved structure. It is noteworthy the presence of mutation C586G in all three Sabin-3 isolates. This substitution is situated in a double-stranded region of domain VI of IRES and leads to a G-G mismatch as the mutations C583G in Sabin-1 isolate (II) and C584G in three Sabin-2 isolates (EP9, IF, and EP12). These mutations may confer a selective advantage in OPV isolates, as they have also been observed in isolates of previous studies [51, 52] . In the VP1 coding region, all three Sabin-3 isolates displayed the reversion at nt 2493 (C→U [Thr-6-Ile]), which is a determinant of attenuation [53] [54] [55] . Residue 6 is situated at the N-terminus of VP1 in the interior of the capsid and the substitution of the attenuating Thr by Ile probably strengthens the hydrophobic interactions between the VP1 amino terminus and endosomal cell membranes during virus cell entry [54, 56] . In isolate EP23, the substitution Ile-258-Val, partially exposed at the outer surface of the virion and near to N-AgI, was also identified.
In the 2C-3D non-structural genomic region of the isolates, nucleotide and amino acid substitutions were also identified ( Table 3) . The reversion at nt 6203 (C→U [His-73-Tyr]) of the 3D polymerase coding region has been correlated with the attenuated and thermosensitive phenotype of Sabin 1 vaccine strain [6, 10, 13, 25, 57, 58] . The C6203U mutation was identified in two recombinant Sabin-2 isolates (EP9: S2/S1 and ID: S2/S1) in a Sabin 1 background, but was not identified in the recombinant isolate EP23 (S3/S1), which also has a Sabin 1 background in the 3D region. The 2C coding region is known to contain a conserved stem-loop structure (nt 4443-4504 in poliovirus type 2) serving as an essential cis-acting replicative element (CRE) involved in the uridylylation of VPg [59, 60] . The substitution of any of the three As of a conserved AAACA sequence (in poliovirus type 1 and type 3) in the loop of the CRE reduces both VPg uridylylation and virus yield [60] . The substitution G4473A in isolate EP9 (S2/S1) converts the conserved AAGCA sequence of Sabin 2 vaccine strain to the conserved AAACA sequence of Sabin 1 vaccine strain. It has been proposed that the presence of G at nt 4473 is implicated in the attenuated phenotype of Sabin 2 vaccine strain [60] .
Discussion
In this study, eight OPV isolates which were isolated from healthy vaccinees and VAPP cases during the period 1978-1985 were investigated. More specifically, we determined the phenotypic traits such as thermosensitivity and growth kinetics of each isolate and attempted to correlate them with genomic modifications.
The Sabin vaccine strains differ from their progenitors in biological properties other than neurovirulence, some of which have been used as in vitro markers to monitor the quality of new batches of vaccine prior to monkey neurovirulence assays. Temperature sensitivity and plaque size have been used as in vitro phenotypic markers in previous studies and were shown to correlate with the neurovirulence of poliovirus [6-10, 13, 25, 45, 58, 61] . The MAPREC test, which is based on the presence of mutations at known major determinants of attenuation, has also been correlated with the neurovirulence of poliovirus [62] . The one-step growth curve experiment was also used as an indication of viral multiplication ability that might correlate with viral virulence [9, 19, [63] [64] [65] .
In the present study, the growth phenotype of eight OPV isolates (two non-recombinants and six recombinants), as well as of Sabin vaccine strains, in Hep-2 cells at two different temperatures (37°C and 40°C) was evaluated using two different assays, Rct test and one-step growth curve analysis. In non-recombinant Sabin-1 isolate (II), the presence of mutations at known determinants of attenuation and thermosensitivity or in other positions of 5′-NCR and VP1 regions involved in virus replication does not favor the reversion of its growth phenotype at both 37°C and 40°C. It is noteworthy the lower virus titer (1 log 10 unit) of isolate II than Sabin 1 vaccine strain at the first stages of the infectious life cycle (0 and 1 h post-infection). This initial difference leads to a lower virus titer of isolate II than Sabin 1 vaccine strain throughout the infectious life cycle and may originate from the different adsorption and/or penetration properties of isolate II in comparison to that of Sabin 1 vaccine strain. However, isolate II showed partial reversion to non-ts phenotype (Rct value=2.0). The presence of many other determinants of thermosensitivity (nt 935, 1944, 2438, and 2741) in the 5′ end of the genome of Sabin 1 vaccine strain makes difficult the reversion of Sabin-1 isolates to a non-ts phenotype [9] .
All Sabin-2 isolates were S2/S1 recombinants. Isolates EP9, IF, and ID showed a non-ts phenotype, while isolate EP12 showed partial reversion to non-ts phenotype, as proved by Rct test values. The different phenotypes of Sabin-2 isolates may correlate with the presence of mutations at nt 398 (isolates EP9 and IF) and at nt 6203 (isolates EP9 and ID). The presence of mutations at nt 481, 584, and 2909 in isolate EP12 seems to have a minor contribution to the reversion to a non-ts phenotype. In the one-step growth curve test, all Sabin-2 isolates displayed similar growth kinetics to Sabin 2 vaccine strain. However, isolates EP9, ID, and EP12 displayed lower virus titer (≤1 log 10 unit) than Sabin 2 vaccine strain at the first stages of the infectious life cycle (0 and 1 h post-infection), as in the case of Sabin-1 isolate II. Moreover, isolate IF showed higher viral yield than Sabin 2 vaccine strain at 4, 8, and 16 h post-infection at 40°C. The discrepancy of the results of the two assays concerning the reversion of thermosensitivity may correlate with the fact that they show viral multiplication for different time periods.
The recombinant Sabin-3 isolates EP16 (S3/S2) and EP23 (S3/S1) reverted partially to non-ts phenotype, while the non-recombinant Sabin-3 isolate 729 displayed a ts phenotype, as seems to be the case from the Rct test value. Isolates EP16 and EP23 replicated efficiently at both 37°C and 40°C in the one-step growth curve test. More specifically, isolates EP16 and EP23 showed 2.0 and 1.7 log 10 units, respectively, higher viral yield than the Sabin 3 vaccine strain at 0 and 1 h post-infection. The presence of specific mutations (U472C, C586G in 5′-NCR, and C2493U in the VP1 coding region) and the recombination events may lead to different properties of isolates in comparison to Sabin 3 vaccine strain. These different properties may lead to the higher viral yield of isolates EP16 and EP23 at the initial stages of the infectious life cycle and to the earlier rise of the virus titer than the Sabin 3 vaccine strain. The non-recombinant isolate 729 replicated with kinetics similar to that of Sabin 3 vaccine strain at both 37°C and 40°C. However, it showed higher viral yield (<1 log 10 unit) than Sabin 3 vaccine strain at 0 and 1 h postinfection as isolates EP16 and EP23. The reversion at nt 2493 may be responsible for the higher viral yield of all three Sabin-3 isolates than the Sabin 3 vaccine strain at the initial stages of the infectious life cycle. Isolates EP16 and EP23 showed mutations at the same determinants of attenuation and thermosensitivity (nt 472 of 5′-NCR and 2493 of VP1) as isolate 729. Consequently, the different phenotypes of isolates EP16 and EP23 in comparison with that of 729 are probably associated with the recombination event. This would be in disagreement with a previous report by Macadam et al. [7] , who showed that similar type 3 recombinant viruses were slightly more ts than their nonrecombinant counterparts containing the same reverted mutations.
Consequently, in non-recombinant Sabin-1 isolate, the presence of mutations at known determinants of attenuation and thermosensitivity does not affect its growth phenotype. Sabin 1 vaccine strain is genetically more stable than Sabin 2 and Sabin 3 vaccine strains, and this fact may explain why Sabin 3 and Sabin 2 are more frequently isolated from VAPP cases than Sabin 1 (only about 12% of cases) [66, 67] . Moreover, the presence of S1/SX (SX: S2 or S3) recombinants is extremely rare. The sequences of Sabin type 1 origin are regularly found in SX/S1 recombinant strains [7, 45, [68] [69] [70] [71] . The above may correlate with the increased fitness of SX/S1 recombinants than that of the S1/ SX recombinants. The determinants of attenuation and thermosensitivity of Sabin 1 vaccine strain are scattered along the whole genome, but most of them are situated in the 5′-NCR and capsid region [9] . Sabin 1 vaccine strain may exchange the 5′ end of its genome with that of Sabin 2 or Sabin 3 vaccine strains in order to get rid of these fitnessdecreasing mutations.
In Sabin-2 isolates, the presence of mutations at nt 398 of 5′-NCR and 6203 of the 3D coding region favors considerably the reversion to non-ts phenotype and may lead to the reversion towards neurovirulence. The mutation at nt 398 of 5′-NCR has been frequently observed in Sabin-2 isolates from VAPP cases [8, 41, 72] . The mutation at nt 6203 of the 3D coding region has also been observed in Sabin-1 isolates from VAPP cases [14, 24, 45] .
In Sabin-3 isolates, the recombination of Sabin 3 vaccine strain with Sabin 1 or Sabin 2 and the acquisition of genome structure S3/S1 or S3/S2 favor the growth phenotype and the reversion towards neurovirulence. This observation is in accordance with the fact that S3/SX recombinants have been frequently isolated from VAPP cases [28, 32, 33, 68, [73] [74] [75] .
Thus, both mutations and recombination could affect the phenotype traits of Sabin derivatives and may lead to neurovirulent viral strains. Moreover, the recombination allows either the congregation of reversed determinants of attenuation and thermosensitivity in the viral genome or the elimination of some determinants of attenuation and thermosensitivity from the viral genome.
In conclusion, both the Rct assay and the one-step growth curve analysis are effective markers for the estimation of the neurovirulence of Sabin derivatives. Moreover, the use of phenotypic markers such as the onestep growth curve analysis and the Rct assay along with the genomic analysis may shed additional light in the molecular determinants of the reversed neurovirulent phenotype of Sabin derivatives.
